147 related articles for article (PubMed ID: 22935070)
1. A review on noscapine, and its impact on heme metabolism.
Singh H; Singh P; Kumari K; Chandra A; Dass SK; Chandra R
Curr Drug Metab; 2013 Mar; 14(3):351-60. PubMed ID: 22935070
[TBL] [Abstract][Full Text] [Related]
2. Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics.
Lopus M; Naik PK
Pharmacol Rep; 2015 Feb; 67(1):56-62. PubMed ID: 25560576
[TBL] [Abstract][Full Text] [Related]
3. Noscapine and its Analogs as Chemotherapeutic Agent: Current updates.
Tomar V; Kukreti S; Prakash S; Madan J; Chandra R
Curr Top Med Chem; 2017; 17(2):174-188. PubMed ID: 27237331
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of N-substituted noscapine analogues.
DeBono AJ; Xie JH; Ventura S; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2012 Dec; 7(12):2122-33. PubMed ID: 23055449
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine.
Zhou J; Gupta K; Yao J; Ye K; Panda D; Giannakakou P; Joshi HC
J Biol Chem; 2002 Oct; 277(42):39777-85. PubMed ID: 12183452
[TBL] [Abstract][Full Text] [Related]
6. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses.
Ke Y; Ye K; Grossniklaus HE; Archer DR; Joshi HC; Kapp JA
Cancer Immunol Immunother; 2000 Jul; 49(4-5):217-25. PubMed ID: 10941904
[TBL] [Abstract][Full Text] [Related]
7. Determination of noscapine's localization and interaction with the tubulin-α/β heterodimer.
Alisaraie L; Tuszynski JA
Chem Biol Drug Des; 2011 Oct; 78(4):535-46. PubMed ID: 21781284
[TBL] [Abstract][Full Text] [Related]
8. The anti-cancer activity of noscapine: a review.
Mahmoudian M; Rahimi-Moghaddam P
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):92-7. PubMed ID: 19149691
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
[TBL] [Abstract][Full Text] [Related]
10. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
[TBL] [Abstract][Full Text] [Related]
11. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
[TBL] [Abstract][Full Text] [Related]
12. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
Landen JW; Hau V; Wang M; Davis T; Ciliax B; Wainer BH; Van Meir EG; Glass JD; Joshi HC; Archer DR
Clin Cancer Res; 2004 Aug; 10(15):5187-201. PubMed ID: 15297423
[TBL] [Abstract][Full Text] [Related]
13. Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.
Lokhorst B; Rolfes L; Jessurun NT
Br J Clin Pharmacol; 2019 May; 85(5):1041-1043. PubMed ID: 30809820
[No Abstract] [Full Text] [Related]
14. Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.
Zhou J; Gupta K; Aggarwal S; Aneja R; Chandra R; Panda D; Joshi HC
Mol Pharmacol; 2003 Apr; 63(4):799-807. PubMed ID: 12644580
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of a cyclic ether fluorinated noscapine analog.
Aneja R; Vangapandu SN; Joshi HC
Bioorg Med Chem; 2006 Dec; 14(24):8352-8. PubMed ID: 17008104
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effects of noscapine through activation of prostaglandin E2 receptors and protein kinase A.
Kach J; Sandbo N; La J; Denner D; Reed EB; Akimova O; Koltsova S; Orlov SN; Dulin NO
J Biol Chem; 2014 Mar; 289(11):7505-13. PubMed ID: 24492608
[TBL] [Abstract][Full Text] [Related]
17. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.
Ye K; Ke Y; Keshava N; Shanks J; Kapp JA; Tekmal RR; Petros J; Joshi HC
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1601-6. PubMed ID: 9465062
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic pathway induced by noscapine in human myelogenous leukemic cells.
Heidari N; Goliaei B; Moghaddam PR; Rahbar-Roshandel N; Mahmoudian M
Anticancer Drugs; 2007 Nov; 18(10):1139-47. PubMed ID: 17893514
[TBL] [Abstract][Full Text] [Related]
19. Biological and pharmacological activities of noscapine: Focusing on its receptors and mechanisms.
Nourbakhsh F; Askari VR
Biofactors; 2021 Nov; 47(6):975-991. PubMed ID: 34534373
[TBL] [Abstract][Full Text] [Related]
20. Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs.
Zughaier S; Karna P; Stephens D; Aneja R
PLoS One; 2010 Feb; 5(2):e9165. PubMed ID: 20161797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
